• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于哮喘的沙丁胺醇-布地奈德固定剂量复方急救吸入器:MANDALA研究的通俗易懂总结

Albuterol-budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study.

作者信息

Papi Alberto, Chipps Bradley E, Beasley Richard, Panettieri Reynold A, Israel Elliot, Cooper Mark, Dunsire Lynn, Jeynes-Ellis Allison, Rees Robert, Albers Frank C, Cappelletti Christy

机构信息

Department of Respiratory Medicine, University of Ferrara Medical School, Ferrara, Italy.

The Capital Allergy and Respiratory Disease Center, Sacramento, CA, USA.

出版信息

Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241232264. doi: 10.1177/17534666241232264.

DOI:10.1177/17534666241232264
PMID:38698565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11067641/
Abstract

This summary describes the results of a clinical study called MANDALA that was published in the in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both and in a single inhaler (known as , AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.

摘要

本摘要介绍了一项名为MANDALA的临床研究结果,该研究于2022年发表。在MANDALA研究中,研究人员观察了一种新型哮喘急救吸入器,该吸入器在一个吸入器中同时含有[具体成分1]和[具体成分2](称为[AIRSUPRA™])。本摘要描述了参与该研究的18岁及以上人群的研究结果。

相似文献

1
Albuterol-budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study.用于哮喘的沙丁胺醇-布地奈德固定剂量复方急救吸入器:MANDALA研究的通俗易懂总结
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241232264. doi: 10.1177/17534666241232264.
2
Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.沙美特罗替卡松干粉吸入剂(舒利迭)治疗哮喘。
N Engl J Med. 2022 Jun 2;386(22):2071-2083. doi: 10.1056/NEJMoa2203163. Epub 2022 May 15.
3
Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.哮喘患者使用可调节剂量和固定剂量的布地奈德/福莫特罗压力定量吸入器与固定剂量的丙酸氟替卡松/沙美特罗干粉吸入器治疗期间患者报告结局的比较。
J Asthma. 2010 Mar;47(2):217-23. doi: 10.3109/02770900903497154.
4
Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.福莫特罗与布地奈德联合用于成人和儿童慢性哮喘的维持和缓解治疗与联合吸入器维持治疗的对比
Cochrane Database Syst Rev. 2013 Dec 16;2013(12):CD009019. doi: 10.1002/14651858.CD009019.pub2.
5
Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.用于哮喘的沙丁胺醇-布地奈德固定剂量复方急救吸入器
Pediatrics. 2023 Dec 1;152(Suppl 3):S52. doi: 10.1542/peds.2023-064344N.
6
Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma.布地奈德/福莫特罗联合吸入器作为毛利人哮喘患者的维持和缓解治疗药物
Respirology. 2014 Aug;19(6):842-51. doi: 10.1111/resp.12319. Epub 2014 Jun 2.
7
[Powder inhaler with integrated motor. The anti-asthmatic drug stays fresh].[带有集成电机的粉末吸入器。抗哮喘药物保持新鲜]。
MMW Fortschr Med. 2001 Apr 19;143(16):58.
8
Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.布地奈德/福莫特罗维持和缓解治疗在亚洲哮喘患者(≥16 岁)中的应用:COSMOS 研究的一项亚分析。
Clin Drug Investig. 2012 Jul 1;32(7):439-49. doi: 10.2165/11598840-000000000-00000.
9
Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.吸入性皮质类固醇或长效β-激动剂单独或固定剂量联合治疗哮喘:氟替卡松/布地奈德和福莫特罗/沙美特罗的系统评价。
Clin Ther. 2009 Dec;31(12):2779-803. doi: 10.1016/j.clinthera.2009.12.021.
10
Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.沙美特罗/丙酸氟替卡松(50/500微克)联合使用的准纳器吸入器(舒利迭)在治疗激素依赖型哮喘方面有效且安全。
Respir Med. 1999 Dec;93(12):876-84. doi: 10.1016/s0954-6111(99)90053-7.

引用本文的文献

1
The Novel Imipramine-Magnesium Complex Exerts Antidepressant-like Activity in Mice Subjected to the Forced Swim Test and the Tail Suspension Test.新型丙咪嗪-镁络合物在强迫游泳试验和悬尾试验的小鼠中发挥出类抗抑郁活性。
Molecules. 2025 Jan 23;30(3):519. doi: 10.3390/molecules30030519.
2
A Fully Decentralized Randomized Controlled Study of As-Needed Albuterol-Budesonide Fixed-Dose Inhaler in Mild Asthma: The BATURA Study Design.按需使用沙丁胺醇-布地奈德固定剂量吸入器治疗轻度哮喘的完全去中心化随机对照研究:BATURA研究设计
J Asthma Allergy. 2024 Aug 23;17:801-811. doi: 10.2147/JAA.S471134. eCollection 2024.